AGLITTI, Andrea
 Distribuzione geografica
Continente #
NA - Nord America 519
EU - Europa 163
AS - Asia 72
Continente sconosciuto - Info sul continente non disponibili 2
OC - Oceania 1
Totale 757
Nazione #
US - Stati Uniti d'America 517
IT - Italia 64
CN - Cina 47
DE - Germania 28
IE - Irlanda 20
TR - Turchia 17
GB - Regno Unito 14
RU - Federazione Russa 11
SE - Svezia 8
UA - Ucraina 7
DK - Danimarca 5
IN - India 3
EU - Europa 2
FR - Francia 2
MY - Malesia 2
RO - Romania 2
TW - Taiwan 2
AU - Australia 1
ES - Italia 1
HN - Honduras 1
MX - Messico 1
NO - Norvegia 1
PH - Filippine 1
Totale 757
Città #
Chandler 94
Princeton 70
Ann Arbor 69
Ashburn 60
Woodbridge 31
Jacksonville 26
Dublin 20
Izmir 17
Beijing 16
Andover 15
Washington 14
Nürnberg 13
Wilmington 12
Houston 8
Nanjing 8
Naples 7
Salerno 7
Fairfield 6
Norwalk 5
Redwood City 5
San Giorgio A Cremano 5
Hebei 4
Jinan 4
Pontecagnano 4
Saint Petersburg 4
Bolzano 3
Falls Church 3
Guangzhou 3
Latina 3
Nanchang 3
Rome 3
Boardman 2
Haikou 2
Kuala Lumpur 2
Mercato San Severino 2
Monte San Giovanni Campano 2
Pellezzano 2
San Diego 2
Seattle 2
Taoyuan District 2
Tianjin 2
Aachen 1
Aversa 1
Bengaluru 1
Cambridge 1
Changsha 1
Chennai 1
Dearborn 1
Esslingen am Neckar 1
Gunzenhausen 1
Islington 1
Leawood 1
London 1
Melbourne 1
Mexico 1
Miami 1
Oslo 1
Pozzuoli 1
Reggio Calabria 1
San Fernando 1
Shenyang 1
Tegucigalpa 1
Walnut 1
Weimar 1
Totale 585
Nome #
Efficacy and safety of new direct antiviral agents in HCV infected patients with Diffuse Large B Cell Non-Hodgkin Lymphoma 89
Sustained virological response by direct antiviral agents in HCV leads to an early and significant improvement of liver fibrosis 86
Liver biopsy in type 2 diabetes mellitus: Steatohepatitis represents the sole feature of liver damage 78
Vascular endothelial dysfunction in inflammatory bowel diseases: Pharmacological and nonpharmacological targets 53
Role of Oxidative Stress in Pathophysiology of Nonalcoholic Fatty Liver Disease 50
Untargeted metabolomics as a diagnostic tool in NAFLD: discrimination of steatosis, steatohepatitis and cirrhosis 50
The diagnostic conundrum in non-alcoholic fatty liver disease 49
Characterisation of asymptomatic patients and efficacy of preventive measures for SARS-CoV-2 infection in a large population of Southern Italy: a cohort study 38
Viral hepatitis: Milestones, unresolved issues, and future goals 38
Real-life effectiveness and safety of Glecaprevir/Pibrentasvir in HCV infected patients with chronic kidney disease 36
Real‐Life Efficacy and Safety of Glecaprevir/Pibrentasvir in HCV Infected Patients with Chronic Kidney Disease 34
Efficacy and safety of glecaprevir/pibrentasvir in renally impaired patients with chronic HCV infection 34
High efficacy of direct-acting anti-viral agents in hepatitis C virus-infected cirrhotic patients with successfully treated hepatocellular carcinoma 33
Hepatitis C virus infection in jail: Difficult-to-reach, not to-treat. Results of a point-of-care screening and treatment program 31
Real-life glecaprevir/pibrentasvir in a large cohort of patients with hepatitis C virus infection: The MISTRAL Study 29
NAFLD and extra-hepatic comorbidities: Current evidence on a multi-organ metabolic syndrome 29
HCV point-of-care screening program and treatment options for people who use drugs in a metropolitan area of Southern Italy 29
Predictors of hepatocellular carcinoma in HCV cirrhotic patients treated with direct acting antivirals 26
Totale 812
Categoria #
all - tutte 2.896
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 2.896


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/201945 0 0 0 0 0 0 0 0 0 9 24 12
2019/202083 24 2 3 2 0 2 9 4 0 18 9 10
2020/2021100 15 1 4 5 5 8 9 8 13 6 21 5
2021/2022129 4 2 5 0 6 2 4 5 21 11 16 53
2022/2023190 19 14 23 17 16 48 0 16 18 2 12 5
2023/2024116 7 8 17 9 20 40 0 9 6 0 0 0
Totale 812